A new breakthrough from Prof. Sylvain Martel, at Ecole Polytechnique de Montréal.
A new breakthrough from Prof. Sylvain Martel, at Ecole Polytechnique de Montréal.
While walking in the old Montreal yesterday night, I was surprised to see one of the projects of my portfolio, MR-SUB, advertised in the streets.
For its first campain of MONTREAL F1RST, MR-SUB has been chosen by the Board of Trade of Metropolitan Montreal as one of the most innovative projects in the province of Québec.
English translation: “First Metropolis, to send a micro-device through the blood vessels”
More about MR-SUB:
Because of the high number of patients diagnosed with cancer, tumor targeting, target chemotherapy and chemoembolization are of special interest for modern medicine. Nevertheless, many tumors are still out of reach to catheterization (in particular the ones that must be targeted in regions only accessible through smaller diameter vessels). Some 40 years after the release of the “Fantastic Voyage”, Professor Sylvain Martel, from École Polytechnique de Montréal, came up with the solution: he developed a MRI based platform which enables to reach targets usually inaccessible to catheterization. Its applications include cells targeting, chemoembolization and local hyperthermia.
It has been a long way since I have written post here. This year again, I will be attending the TechConnect Summit in June and I recommend everyone to participate.
The TechConnect Summit will take place June 22-25, 2010, in Anaheim, CA, US. TechConnect is the largest conference in the US focused on emerging technology commercialization and business for nanotechnology, cleantechnology, and the life sciences.
The TechConnect program platform focuses on technology matchmaking
between F1000 corporations and leading universities from around the
world.
TechConnect has great support of the F500 corporate community as both speakers and advisors. Confirmed presenters for the 2010 Summit
include business and technology development executives from: Applied Materials, BP, Fuji Electric, GE Healthcare, Kodak, Lockheed Martin, Medtronic, Merck, Panasonic, Procter & Gamble, Omron, Sanyo, and Toray.
There are several ways to participate:
Present a Technology (IP), Submissions Due February 12
Present a Venture, Submissions Due February 12
Attend, Online Registration Now Open:
Please visit the TechConnect Summit 2010 home page for more details, or contact
Jennifer Rocha at jrocha@techconnect.org.
Repost from www.univalor.ca
Allostera Pharma inc. closed $17M (CAD) Series A financing.
Allostera Pharma Inc. announced yesterday that “it has secured a Series A financing of $17 million.
Four venture funds participated: iNovia Capital, Genesys Capital, BDC Venture Capital with GO Capital, and Fonds Bio-Innovation s.e.c. The proceeds of the financing will be used for the development of Allosteramers™, a new class of drugs developed by Allostera scientists that are both highly specific for their targets and designed to be orally bioavailable. Additionally with these proceeds, Allostera plans to complete preclinical studies and begin human clinical testing of its lead Allosteramer™, APG2305, a novel drug candidate for treating autoimmune diseases like psoriasis that has demonstrated oral activity in animals. The specific terms of the Series A preferred share financing were not disclosed.”
To read the press release, please click here.
Congrats to Anne-Marie, Hélène and Marc for this great job!
Repost from www.univalor.ca
The AUTM Better World Report illustrates the real impact of technology transfer.
In its last edition, a technology recently licensed by Univalor to the South Korean company, Dongil Rubber Belt Co. Ltd. is presented:
“Brace Buffers Buildings to Protect People and Profits” (on page 75).
One of the cool projects that I presented last week at TechConnect Summit (which by the way was a great success. Congrats to Jennifer for the organization!), is a wearable photonic colored fibers developed by Pr. Maksim Skorobagatiy at Ecole Polytechnique de Montreal.
Smart textiles are now everywhere (Frost and Sullivan estimates that in 2020, 80% of the textile will be smart!). Applications already include interactive clothing for sports, hazardous occupations, and military, industrial textiles with integrated sensors or signage, fashion accessories and apparel with unique and variable appearance, etc…
Mainly because of their commercial availability but also their low cost, photonics textile manufacturers usually use silica glass-based telecommunication fibers which cause several challenges in the textile world (How to extract the color from the fiber core? How to generate the color? How to weave them? etc…).
Here comes Pr. Skorobogatiy’s invention!
Instead of using glass-based fibers, he proposes to use photonics crystal fibers made of different layers of polymers which will act as a spectral filter. Therefore, from a single white light source, only a given color will be leaked out of the fiber.
No more need to paint the fiber or to use 3 RGB LED, the color is defined by the fiber design itself (geometry, polymers used, etc…)!
Finally, one of the cool properties of Maksim’s fibers is their ability to change color by mixing the reflected ambient light with the irradiated guided light (inside the fiber).
Under the daylight illumination, and in the absence of guided light, in the fiber is still colored. Consequently, when both the ambient illumination and guided light are present, the overall color of the fiber will be determined by mixing of the two colors in the radiation far field (ex : green + red = yellow).
Applications of this new invention include the development of variable colored uniforms or signs. It could also be used as an anti‐counterfeit label or an intelligent jewelry.
Check out the prototypes’ pictures on Pr. Skorobogatiy’s website. They’re amazing!
As usual, I welcome your comments and feedbacks! Any other idea of applications?
Thomas